✦ LIBER ✦

Commentary: outcomes after escalation of infliximab in moderately active ulcerative colitis – author's reply

✍ Scribed by A. C. Moss

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Commentary: outcomes after escalation of

✍ S. Halpin; P. J. Hamlin 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Outcomes after escalation of infliximab

✍ E. Rostholder; A. Ahmed; A. S. Cheifetz; A. C Moss 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

A comparison of physician-rated disease

✍ Chris D. Poole; Mark P. Connolly; Sandy Kildegaard Nielsen; Craig J. Currie; Phi 📂 Article 📅 2010 🏛 Oxford University Press 🌐 English ⚖ 229 KB

Predictive value of patient-reported out

✍ Colombel, J.F.; Han, C.; Reinisch, W.; Feagan, B.; Marano, C.; Strauss, R.; Joha 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 65 KB

P394 Rate of and response to dose escala

✍ Wolf, D.; D'Haens, G.; Sandborn, W.; Colombel, J.-F.; Van Assche, G.; Lazar, A.; 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 62 KB

T1139 The ACT Trials: Incremental Benefi

✍ Sandborn, William J.; Rutgeerts, Paul J.; Feagan, Brian; Reinisch, Walter; Olson 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 203 KB